Diagnosis, phenomenology and treatment of poststroke depression

Revista Brasileira de Psiquiatria

Volumn 24, Issue 1, 2002, Pages 44-49

  Starkstein, Sergio E ^a,c   Lischinsky, Alicia ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^c Buenos Aires Neuropsychiatric Center   (Argentina)

Author keywords

Antidepressants; Anxiety; Depression; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; HEMIPLEGIA; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTICENTER STUDY; POSTSTROKE DEPRESSION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SEDATION; SEIZURE; STROKE; TREATMENT OUTCOME;

EID: 0036128808     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462002000100011     Document Type: Review

References (28)

1. Major depression and physical illness: Special considerations in diagnosis and biologic treatment
2. Substituing nonsomatic for somatic symptoms in the diagnosis of depression in elderly male medical patients
3. Measurement of depression in patients with cancer
4. Depression in hospitalized cancer patients
5. Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke
6. The structured clinical interview for DSM-III-R (SCID): I. History, rationale, and description
7. An inventory for measuring depression
8. A scaled version of the general health questionnaire
9. A new depression scale designed to be sensitive to change
10. The CES-D Scale, a self-report depression scale for research in the general population
11. Phenomenological comparison of functional and poststroke depression
12. Are depressive symptoms non-specific in patients with acute stroke?
13. Phenomenological comparison of functional and poststroke depression
14. A rating scale for depression
15. Antidepressant therapy after stroke: A double-blind trial
16. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram
17. Effects of early treatment of post-stroke depression on neuropsychological rehabilitation
18. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
19. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy
20. Therapy of early poststroke depression with venlafaxine: Safety, tolerability, and efficacy as determined in a open, uncontrolled clinical trial
21. Fluoxetine in early poststroke depression
22. Prevention of poststroke depression: 1 Year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy
23. Nortiptyline versus Fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study